✦ LIBER ✦
Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi-allelic disease, indicating that heterozygous disease alone is associated with an adverse outcome
✍ Scribed by Claire Green; David C. Linch; Rosemary E. Gale
- Book ID
- 108675809
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 124 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.